BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4643813)

  • 21. [DETERMINATION OF THE AMINO ACIDS OF THE UREOPOIETIC CYCLE OF KREBS-HENSELEIT: L-ARGININE, L-ORNITHINE AND L-CITRULLINE].
    CAVICCHINI G; FAZI L; ALMIRANTE L
    Boll Chim Farm; 1964 Jan; 103():65-8. PubMed ID: 14131379
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Krebs-Henseleit urea cycle in cultured human diploid fibroblasts.
    Elsen A
    Arch Int Physiol Biochim; 1975 Feb; 83(1):204-5. PubMed ID: 50817
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical observations on the therapeutic efficiency of the combination: arginine HCl, citrulline, ornithine HCl, vitamin B-12, folic acid and nicotinamide in liver diseases and in anemic deficiency syndromes].
    Drago U; Finotto E; Ongaro G
    Minerva Med; 1967 Apr; 58(34 Suppl):1592-6. PubMed ID: 4226044
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-experimental findings on the use of a new liver protective agent].
    Catalfamo G; Melotti G; Soffritti E
    Minerva Med; 1967 Apr; 58(34 Suppl):1605-12. PubMed ID: 4226047
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinico-metabolic observations on the use in therapy of a combination of vitamin B-12, folic acid, nicotinamide and amino acids of the arginine group in patients with chronic liver diseases].
    Piro E; Nicoletti A; Ruffolo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1629-33. PubMed ID: 4226052
    [No Abstract]   [Full Text] [Related]  

  • 26. A new transport interaction of dibasic amino acids and citrulline in human kidney.
    Oyanagi K; Sogawa H; Minami R; Nakao T; Karube K; Tsugawa S
    Tohoku J Exp Med; 1981 May; 134(1):55-8. PubMed ID: 6797099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of L-arginine supplementation on the plasma amino acid spectrum in burn patients].
    Lu SL; Ge K; Xie T; Jin SW; Shi JX
    Zhonghua Shao Shang Za Zhi; 2005 Aug; 21(4):247-50. PubMed ID: 16185403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variations in the plasma concentration of ornithine, citrulline and arginine in acute experimental liver failure].
    Soláini G; Mazziótti A; Solaini L; Cacciari G; Cávallari A
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):705-10. PubMed ID: 7272044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ammonia metabolism, urea cycle capacity and their biochemical assessment.
    Visek WJ
    Nutr Rev; 1979 Sep; 37(9):273-82. PubMed ID: 394043
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metabolic alkalosis: treatment with amino acid solutions containing arginine hydrochloride].
    Evora PR; Reis CL; Ribeiro PJ; Brasil JC; Silva JR; Otaviano AG; Margarido EA
    Rev Paul Med; 1981; 97(1-3):25-8. PubMed ID: 7323580
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experimentation with a new pharmacologic combination having a liver protective and detoxicant scope].
    Rossini A; Merlini R
    Minerva Med; 1967 Apr; 58(34 Suppl):1613-7. PubMed ID: 4226048
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical considerations on the use of a new preparation with hepatoprotective action].
    Di Lorenzo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modification of experimentally induced endogenous hyperammoniemia by amino acids in the rat].
    Hermann G
    Arzneimittelforschung; 1970 Mar; 20(3):377-9. PubMed ID: 5467512
    [No Abstract]   [Full Text] [Related]  

  • 34. Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection.
    Osowska S; Moinard C; Neveux N; Loï C; Cynober L
    Gut; 2004 Dec; 53(12):1781-6. PubMed ID: 15542514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experimentation with a new preparation: Polilevo].
    Floris E; Mura B
    Minerva Med; 1967 Apr; 58(34 Suppl):1633-4. PubMed ID: 4226053
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduced citrulline availability by OTC deficiency in mice is related to reduced nitric oxide production.
    Luiking YC; Hallemeesch MM; van de Poll MC; Dejong CH; de Jonge WJ; Lamers WH; Deutz NE
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1315-22. PubMed ID: 18697914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An important role for pentose cycle in the synthesis of citrulline and proline from glutamine in porcine enterocytes.
    Wu G
    Arch Biochem Biophys; 1996 Dec; 336(2):224-30. PubMed ID: 8954569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of hyperammoniemia].
    Nordmann R
    Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.